phase ii study of adjuvant everolimus on pancreatic neuroendocrine tumors of the liver
Published 10 years ago • 1.2K plays • Length 4:20Download video MP4
Download video MP3
Similar videos
-
5:52
everolimus in pancreatic neuroendocrine tumors and carcinoid tumors
-
3:35
everolimus in pancreatic neuroendocrine tumors
-
4:38
everolimus and sunitinib in pancreatic neuroendocrine tumors
-
3:33
radiant-3 trial: everolimus in pancreatic neuroendocrine tumors
-
1:15
ask dr. libutti: what are the signs and symptoms of neuroendocrine tumors?
-
2:14
dr. james c. yao on everolimus in pancreatic neuroendocrine tumors
-
10:00
case study: treating metastatic pancreatic neuroendocrine tumors
-
14:21
liver-directed therapies in pancreatic neuroendocrine tumors
-
2:01
dr. james yao on everolimus in advanced pancreatic neuroendocrine tumors
-
3:14
everolimus for non-functional neuroendocrine tumours
-
5:03
treating pancreatic neuroendocrine tumors
-
5:43
targeted therapies for the treatment of nets
-
6:00
treatment sequencing and combinations in pancreatic neuroendocrine tumors
-
7:33
alkylating agents in pancreatic neuroendocrine tumors
-
22:19
medical management of lung nets, ed wolin, md, mount sinai, ny
-
9:05
role of somatostatin analogs in pancreatic neuroendocrine tumors
-
0:28
ask dr. libutti: how common are neuroendocrine tumors?
-
1:52
clinical trials at the montefiore einstein center for care
-
3:39
targeted therapies in neuroendocrine tumors